What to do when a patient’s asthma control deteriorates after switching to a more environmentally friendly, or ‘greener’, ...

Iconovo AB (publ.), a leader in the development of inhalable drugs based on proprietary inhalers and dry powder formulations, today announces that it has agreed to conduct a feasibility study on behal ...

Patients who switched from a pressurized metered dose inhaler (pMDIs) to a dry powder inhaler (DPI) halved their carbon footprints while still maintaining good asthma control, a post-hoc analysis of ...

Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for ...

About Kinaset Therapeutics, Inc. Kinaset Therapeutics is focused on developing inhaled therapeutics to address significant unmet medical needs in respiratory diseases. With founding investors 5AM ...

Firms should seek out opportunities to unload capital, drive portfolio growth and prove PE’s potential to their investors. Private equity must invest unused capital (“dry powder”) or risk losing ...

People prescribed beclometasone inhalers are encouraged to read up on the NHS guidelines for the drug. The inhalers are often prescribed for people with asthma, and sometimes for other respiratory ...

Choosing between baking soda and baking powder is one of those small decisions that quietly determines whether a recipe turns out light, tender, and evenly risen, or flat, dense, and oddly bitter.

Winter is the best time to year to invest in one of the best dehumidifiers. Due to the cold and wet weather, there tends to be more moisture in the home, and a dehumidifier can help combat that – but ...

Ironing remains a key part of everyday clothing care, even as fabric technology continues to evolve. A good iron helps clothes look sharp, presentable, and long-lasting. When choosing a steam iron for ...

It was the best of times, it was the worst of times. As the year draws to a close, a mixed picture emerges in the private equity industry; while deal size is up, volumes are down, and the performance ...